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of Lund, S-214 01 Malm6, Sweden. 
Objectives: To clarify the effects of unfractionated heparin (UH) and low molecular weight heparin (LMWH) on 
proliferating human smooth muscle cells (SMC) compared togrowth arrested SMC. 
Design: A cell culture study where proliferating SMC were exposed to different concentrations of UH and LMWH and 
the effect on proliferation and collagen secretion was studied. Growth arrested SMC were stimulated with serum and the 
effect of UH on proliferation was measured. 
Setting: Sections of Medical Angiology and Vascular Surgery, Malm6 General Hospital, Sweden. 
Materials: Human SMC were established from arterial tissue obtained at vascular surgery or at organ donation. 
Chief outcome measures: Effects of UH and LMWH on total cellular DNA, 3H-thymidine incorporation and collagen 
secretion using proliferating and growth arrested human SMC in culture. 
Main results: In proliferating SMC that had not been growth arrested, 1and 10 IU/ml UH and LMWH significantly 
increased total cellular DNA compared tocontrols while DNA synthesis was not influenced. The higher cellular DNA was 
probably not a consequence of increased proliferation as DNA synthesis was not affected by UH or LMWH. The increased 
total cellular DNA could instead be due to reduced cell death. Higher concentrations (10 IU/ml) of UH and LMWH also 
increased collagen secretion. In control experiments with UH DNA, synthesis was decreased in stimulated human SMC 
that had been growth arrested previously to heparin exposure. 
Conclusions: The effects of UH and LMWH on SMC proliferation will depend on the proliferative state of the SMC. The 
results might be of relevance for the understanding of the atherosclerotic process and for pharmacologic interventions to
prevent restenosis after angioplasty orsurgery. 
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Introduction 
Heparin is an effective inhibitor of SMC proliferation 
and migration both in vivo and in vitro. 1-3 Further- 
more, heparin influences the composition of the 
cellular matrix. In vivo elastin and collagen are 
reduced while proteoglycans are increased. 4 The 
mechanism behind these effects of heparin have not 
been clarified, but the inhibitory effect on cell pro- 
liferation seems to include rapid internalisation 
through high affinity receptorsS and intracellular 
metabolism of heparin. 6 
Heparin has been shown to reduce intimal thicken- 
ing after arterial injury in animal models. 7 These data 
have provided evidence that heparin treatment must 
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be started within the first 24 h after injury to be 
effective, s However, in man, heparin does not prevent 
myointimal hyperplasia n vein grafts 9and 18-24 h of 
heparin administration after coronary angioplasty did 
• 10 not decrease the incidence of late restenosxs. In the 
normal uninjured arterial wall, almost all SMC are in: 
the non-proliferating ( rowth-arrested) state while a 
substantial proportion of the cells are in the proliferat- 
ing state after different forms of arterial injury. 11 The 
fibrous cap of the atherosclerotic plaque is made up of 
a subintimal proliferation of SMC that also have 
synthesised the extracellular matrix surrounding 
them. 12 In most in vivo and in vitro models concerned 
with the effect of heparin on SMC proliferation, effects 
after stimulation of growth arrested cells have been 
studied. 
The fact that heparin has not been shown to inhibit 
SMC proliferation in humans, i.e. restenosis after 
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angioplast3~ led us to compare the effects of UH and 
LMWH on growth parameters of human SMC in 
different proliferative state in vitro. 
Materials and Methods 
Cell culture 
Segments of different arteries were obtained at vas- 
cular surgery (n = 19) or from organ donors (n = 5) 
(ethical approval was obtained from the Swedish 
Social Welfare Board). The mesenteric, iliac and 
femoral arteries were used as well as pieces from the 
thoracic and abdominal aorta. The arteries were 
immediately put into 0.15 mol/1 saline (4°C) for a 
maximum of 8 h until cultures were established. 
Explants from medial segments of the arteries were 
used for the establishment of cultures as previously 
described. 13Cells were grown in minimal essential 
medium (MEM, Gibco), Hepes buffered 25 mmol/1, 
supplemented with 10% fetal bovine serum (FBS) 
(KEBO, heat inactivated) and 10% human serum 
(HS) (obtained from the blood bank), L-glutamine 
585 mg/l, benzylpenicillin 150/zg/ml and streptomy- 
cin 100/zg/ml. Subcultures (1:2 split) were obtained 
by the use of trypsin 0.05%-EDTA 0.02%. 
Confluent cells from passage two to five were 
trypsinised and counted, the cell suspension was then 
transferred to multiwell dishes (NUNC, 24 wells/ 
dish). Each well contained 3-4 × 104 cells in 1 ml 
medium from the start, and growth was established 
during 24 h. After this period cell layers were 30-50% 
confluent. 
Experimental procedure 
Unfractionated heparin (5000 IU/ml) and low 
molecular weight heparin (Fragmin R) (2500 IU/ml) 
were obtained from Kabi-Pharmacia and diluted with 
MEM to obtain a concentration of i and 10 IU/ml for 
both UH and LMWH. The lower concentration corre- 
sponds to that obtained with heparin treatment in a 
clinical situation. 
The medium was changed to MEM, with 5% FBS 
and 5% HS, and 200/zl of the standard solutions of UH 
and LMWH were added. Controls received 200 /zl 
serum free (SF) MEM. The cultures were incubated for 
72 h. Total cellular DNA was measured from the start 
and after 72 h, 3H-thymidine incorporation between 
20 and 24 h and collagen between 24 and 72 h. 
Human SMC were growth arrested in SF MEM for 
24 h whereafter fresh medium with 5% FBS/5% HS 
was added together with UH. 3H-thymidine incor- 
poration was assayed between 20 and 24 h. 3H-thymi- 
dine incorporation at the start of the experiments (O h) 
was 150-300 dpm/dish for growth arrested cells and 
1.087-19.757 dpm/dish for proliferating human 
SMC. 
Measurements 
To measure DNA synthesis, 0.0033 ~zCi/ml medium of 
methyl-(3H)-thymidine (Amersham, specific activity 
25 Ci/mmol) was added to each dish after 20 h 
incubation. Four hours later 3H-activity was deter- 
mined as previously described. 13
Cells were scraped with a teflon policeman from 
each dish to determine total cellular DNA. 14 
Cells were labelled with 5-3H-proline (1.25/~Ci/ml) 
(Amersham) during 48 h. The newly synthesised 
3H-labelled collagen was determined after pepsin 
digestion and successive salt precipitations atacid and 
neutral pH in the presence of carrier collagen as 
described by Webster and Harvey. is 
Cell counting was performed in a Burker haemocyt- 
ometer chamber and radioactivity counted in a Tri- 
Carb 300 CD liquid scintillation spectrometer. The 




No significant differences in DNA synthesis between 
controls and cells exposed to 1 or 10 IU/ml UH or 
Table 1. Effects of UH and LMWH on DNA synthesis of 
proliferating human SMC 
Concentration Control UH LMWH 
1 IU/ml 4469 *+ 3559 *+ 3683 + 
(n=24) (2039-5639) (2306-5461) (2124-5304) 
10 IU / ml 50395§ 50285§ 4457§ 
(n=18) (3235-10129) (2686-9946) (3284-9540) 
*NS; +NS; 5NS; ~NS 
The values represent 3H-thymidine incorporation (dpm/dish). 
Results are presented as median value with interquartile range, the 
latter in parentheses. Triplicate dishes were used. n=number of 
experiments. 3H-thymidine incorporation was assayed after 20-24 h 
incubation. 
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LMWH were found (Table 1). The supply of cells in 
some experiments was insufficient which explains the 
somewhat smaller number of experiments with the 
higher concentration. 
Table 2. Effects of UH and LMWH on total cellular DNA of 
proliferating human SMC 
Concentration Start Control UH LMWH 
1 IU/ml 0.47 0.63 *t 0.70 *t 0.73 t 
(n=24) (0.35--0.52) (0.58-0.78) (0.64-0.83) (0.60-0.86) 
10 IU/ml 0.46 0.65~§ 0.72~§ 0.75§ 
(n=18) (0.36-0.51) (0.60-0.73) (0.58-0.80) (0.61-0.79) 
*p < 0.005; tp < 0.005; ~p < 0.05; §p < 0.05 
The values represent/~g DNA/dish. The results are presented as 
median value with interquartile range. Conditions otherwise 
identical to Table 1. DNA was measured at start and after 72 h 
incubation. 
The results for total cellular DNA are shown in 
Table 2. The clear increase of cellular DNA in controls 
between start and 72 h indicated that the cells were 
proliferating. A concentration of 1 IU /ml  UH or 
LMWH caused an increase in total cellular DNA 
compared to controls (p < 0.005). For 10 IU /ml  of UH 
and LMWH similar results were obtained (p < 0.05). A 
concentration of 1 IU /ml  UH and LMWH did not 
influence collagen secretion (Table 3) while 10 IU /ml  
UH and LMWH increased collagen secretion (p < 0.05 
and 0.005 respectively). 
Table 3. Effects of UH and LMWH on secretion of newly 
synthesised collagen by proliferating human SMC 
Concentration Control UH LMWH 
1 IU/ml 2580 *+ 2413 *t 2600 ~ 
(n=24) (1908--3893) (1716-4816) (1821-4452) 
10 IU / ml 2975~§ 38895§ 5468§ 
(n=18) (2065--5683) (1864--6342) (3599-7868) 
*NS; tNS; ~p < 0.05; §p < 0.05 
The values represent collagen secretion (dpm/dish) per total cellular 
DNA (dpm/l~g). Experimental conditions as in Tables 1 and 2. 
Collagen was assayed at 24-72 h. 
Growth arrested cells 
In six experiments with human SMC, 3H-thymidine 
incorporation was measured in cells that were stimu- 
lated with serum after they had been growth arrested 
(Table 4). In parallel cultures, proliferating SMC were 
grown as previously described. Under these condi- 
tions, i and 10 IU/ml  UH inhibited DNA synthesis by 
Table 4. Effects of UH on DNA synthesis of proliferating and 
stimulated growth arrested human SMC 
Concentration Growth arrested SMC Proliferating SMC 
(n=6) (n=6) 
Control 5683 *t 4264*§ 
(5238-6436) (4006-4532) 
1 IU/ml 4159 *~ 4238~§ 
(3867-4676) (3998--4459) 
10 IU/ml 3750 t 4158§ 
(3145-4218) (3879-4458) 
*p < 0.05; ~ p < 0.05; ~NS; §NS 
Parallel experiments were performed with the same cell population 
and passage comparin~ proliferating and previously growth arrested 
cells. The values how H-thymidine incorporation/dish. Each value 
represents mean of six identical experiments u ing triplet dishes, the 
interquartile range is given within parentheses. DNA synthesis was 
measured between 20-24 h of incubation. 
27-34% in stimulated, previously growth arrested 
cells (p<0.05) while proliferating cells were not 
inhibited. 
Discussion 
Heparin and heparin-like molecules are well estab- 
lished inhibitors of SMC proliferation, but the vast 
majority of experiments, both in vivo and in vitro, have 
been performed with growth-arrested cells that were 
stimulated by arterial wall injury and/or  addition of 
growth factors. 1-3 In the present study we have used 
proliferating human SMC and compared the effects of 
UH and LMWH to those on growth-arrested SMC that 
were growth stimulated with serum. The main finding 
was that proliferating cells were not growth inhibited 
by UH or LMWH in our model. Recently, Caplice et al. 
have reported that the proliferative state of the cells 
involved in outgrowth from coronary artery explants 
may influence the activity of heparin. 16 Their findings 
were quite similar to ours. Furthermore, and in 
contrast o previous studies, 4 we found that collagen 
secretion was not influenced (1 IU /ml  UH and 
LMWH), or was increased (10 IU /ml  UH and 
LMWH). 
For comparison, human SMC were growth arrested 
and then stimulated by the addition of serum. The 
expected inhibition of proliferation by UH was 
obtained, thus ruling out the possibility that the drug 
was pharmacologically inactive in our models. 
The human SMC were obtained from both normal 
arterial segments (no macroscopic atherosclerosis) and 
from pieces affected by atherosclerosis. No differences 
between cells derived from these different segments 
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with respect to the reaction to UH or LMWH could be 
detected. Furthermore, there were no differences 
between cells from different arteries concerning the 
parameters tudied. Therefore all cells could be 
regarded as similar. SMC from organ donors were 
generally derived from less atherosclerotic segments 
than those from vascular surgery patients, The organ 
donors were also, in most cases, younger than the 
surgical patients. Growth was established from 
approximately 60% of the vascular surgery tissue and 
90% of organ donors. The latter SMC could generally 
be propagated to the fifth or sixth passage while the 
fourth passage was seldom reached with cells from 
atherosclerotic tissue. 
3H-thymidine incorporation was analysed after 24 h 
while cellular DNA and collagen secretion was deter- 
mined after 72 h. The reason for this was that the 
3H-thymidine method will detect differences in DNA 
synthesis within the first 24 h after stimulation, 
corresponding roughly to one cell cycle. In contrast, 
longer incubation time is needed to detect differences 
in cellular DNA or collagen secretion. 
We used 24 h in SF MEM to obtain growth arrest. 
Periods longer than 24 h will result in extensive cell 
detachment and will not decrease the 3H-thymidine 
count further. Therefore we considered the cells after 
24 h in SF MEM to be growth arrested. Cell detach- 
ment within 24 h was 10-20%. 
UH and LMWH increased total cellular DNA 
compared to controls. Total cellular DNA is a good 
parameter for cell number and, in our experience, 
better than cell counting. The cell number is a balance 
between cell proliferation and cell death, and therefore 
the increased DNA values after exposure to UH and 
LMWH were not necessarily due to stimulation of 
SMC proliferation. As 3H-thymidine incorporation did 
not differ between the different groups, a possible 
interpretation would be that different heparins may 
reduce cell death. There is some support for this 
explanation in the literature. 17 Other reports have 
shown that heparin will potentiate the effect of some 
growth fact0rs. 18'19 Similarl3¢ the effects on collagen 
secretion may be a consequence of reduced cell death, 
but the clear increase, at least with 10 IU/ml LMWH 
also suggests ome direct stimulating effect. 
The results obtained stress the importance of clearly 
identifying whether effects of UH or LMWH are 
studied on proliferating or growth arrested SMC as 
theresults may be quite different. The results may also 
explain why the inhibiting effects of heparin on SMC 
proliferation shown in animal models and in vitro are 
not. always as clear when studied in more clinical 
situations, for example prevention of restenosis after 
angioplasty or suppression of intimal proliferation in 
vein grafts. 9In these models it is not evident hat the 
majority of cells are growth arrested, as traumatisation 
of the arterial wall could be caused by the operative 
procedures or the atherosclerotic process. 
We conclude that UH and LMWH do not inhibit 
proliferation of proliferating human SMC, in contrast 
to previously stimulated growth arrested SMC. 
Instead, there were indications that UH and LMWH 
may reduce cell death of proliferating SMC in vitro as 
well as supporting collagen secretion. The results 
may be of importance for the understanding of 
pharmacological intervention of uncontrolled SMC 
proliferation. 
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